Managing multiple myeloma in 2023

Multiple Myeloma Program - Dana-Farber Cancer Institute

Consultation and confirmation of diagnosis · Development of a personalized treatment plan offering the latest therapies (combination chemotherapy, novel ...

Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma

Up-front treatment for newly diagnosed transplant-eligible multiple myeloma includes quadruplet pretransplant induction and post-transplant ...

Treatment Options for Multiple Myeloma and Other Plasma Cell ...

For people who can't get a stem cell transplant, treatment with the same medicines is usually continued as long as it's effective, for up to ...

Lenalidomide use in multiple myeloma (Review)

The application of lenalidomide for the treatment of MM was approved by the FDA in March 2006. Since then, clinical trials and real-world ...

An overview of multiple myeloma: A monoclonal plasma cell ...

Thalidomide and its analogues, lenalidomide and pomalidomide, are IMiDs used in MM treatment, known for their antiangiogenic activity. IMiDs are commonly ...

Multiple Myeloma - The ASCO Post

In newly diagnosed, transplant-ineligible patients with multiple myeloma, treatment with the anti-CD38 monoclonal antibody isatuximab plus bortezomib, ...

New treatment option for adult multiple myeloma

The drugs daratumumab plus lenalidomide and dexamethasone are recommended for previously untreated multiple myeloma in adults.

Dr. C. Ola Landgren on Quadruple Therapies and the Future of ...

Patients with newly diagnosed multiple myeloma are increasingly being treated with a four-part drug combination that includes a new ...

Multiple Myeloma: Management of Relapsed/Refractory Disease

CAR-T cell therapy for myeloma is currently not funded in Alberta. Page 9. 9. Guideline Resource Unit. Last revision: September 2023.

The addition of daratumumab to RVD deepens treatment responses ...

ASH 2023 | The addition of daratumumab to RVD deepens treatment responses in t(11;14) multiple myeloma ... Sagar Lonial, MD, Winship Cancer ...

Immunotherapy for Multiple Myeloma - Cancer Research Institute

Immunotherapy for multiple myeloma is a promising new treatment option, with the potential to result in long-term cancer remission similar to the results of ...

Perspectives on the Treatment of Multiple Myeloma - Oxford Academic

1 According to the American Cancer Society, an estimated 35 730 new cases of MM will be diagnosed in the US in 2023, and ~12. 590 deaths will be ...

Investigational drug may improve stem cell transplantation for ...

The standard treatment for patients with multiple myeloma often includes stem cell transplantation in which the patient's own stem cells are ...

Multiple myeloma: challenges with deciding the optimal sequencing ...

(Cliff and Rehman Mohyuddin, 2022; Etekal et al., 2023) While some MM RCTs such as SWOG 0777 and MAIA showed PFS and OS benefits with addition of bortezomib or ...

Chemotherapy for Multiple Myeloma | LLS

The main treatment for active myeloma is systemic drug therapy (meaning the drugs travel through the bloodstream to kill malignant cells).

Emerging Treatment Landscape for Multiple Myeloma

A common theme among many of the sessions presented at the ONS 2023 Congress was the continually emerging treatment landscape for patients with multiple ...

Management of Newly Diagnosed Multiple Myeloma Today, and in ...

Quadruplet therapy incorporating daratumumab has been practice changing in newly diagnosed multiple myeloma. ... Treatment of high-risk myeloma is ...

Changing Treatment Paradigms for Patients with Multiple Myeloma

Currently, there is no cure for multiple myeloma, however there are treatments that can help people live longer, healthier lives. Stem cell transplant is a ...

Multiple Myeloma - ASH 2023 Update - OHSU

2023;142(Suppl_1):535. Long TE. Blood Cancer Journal. 2022;12(9):133. https://istopmm.com/riskmodel/. Page 32. 32. MGUS: Management Pathways. • #3719: The ...

Myeloma Treatment and Survival Rate | City of Hope

The standard of care for people who are newly diagnosed with multiple myeloma is initial induction therapy, followed by a stem cell transplant ...